A Clinical Study to Evaluate the Efficacy of Four Supplements on Improving Readiness for Intimacy

Libido Clinical Trial

Official title:
A Single-Group, Open-Label Clinical Study to Evaluate the Efficacy of Four Supplements on Improving Readiness for Intimacy

Status Active, not recruiting

Clinical Trial Summary

This study is to evaluate the efficacy of four supplements designed to help participants get ready for sexual intimacy through improving digestion, weight management, sexual drive and stamina, and physical endurance during workouts and overall mood and quality of life. This study will be conducted as a single group, virtual trial, in which all participants will take all four supplements and complete online questionnaires. Participants will take the indicated supplements for the indicated amounts of time over 12 weeks. Questionnaires will be completed at baseline, and then at indicated times throughout the trial.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Libido

Clinical Trial Details

NCT number	NCT05862519
Study type	Interventional
Source	906 CMVI Holdings
Contact
Status	Active, not recruiting
Phase	N/A
Start date	March 14, 2023
Completion date	June 13, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01977313` - Genetic Polymorphism of the Androgen Receptor-Gene and Sexual Function in Middle Aged Women	N/A
Completed	`NCT00566384` - Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido	Phase 2
Completed	`NCT00764881` - Effects of SH T00658ID on Libido	Phase 3
Completed	`NCT05258513` - The Effects of Geranylgeraniol (GG) Sourced From Annatto on Sexual Health	N/A